ID
AXON

Integral Derivatives’s Axon Enterprise AXON Stock Holding History

Integral Derivatives’s Portfolio AXON Stock Details AXON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-9,930
Closed -$331K – 1089
2015
Q2 		$331K Buy
+9,930
New +$310K 0.01% 839

Other funds holding AXON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Integral Derivatives's AXON Position: Q3 2015 in Review

Integral Derivatives sold out of Axon Enterprise (AXON) in Q3 2015, closing a stake of 9,930 shares — an estimated $331K sold.

Integral Derivatives first reported a position in AXON in Q2 2015 and held it in 1 quarter. The position peaked at $331K in Q2 2015. 198 funds tracked by Wall St. Rank hold AXON as of Q3 2015.

  • Integral Derivatives reported no remaining Axon Enterprise position as of Q3 2015 after selling out during the quarter.
  • Integral Derivatives sold 9,930 Axon Enterprise shares in Q3 2015, an estimated $331K.
  • Integral Derivatives first reported a position in Axon Enterprise in Q2 2015 and held it in 1 quarter.
  • Integral Derivatives's Axon Enterprise position peaked at $331K in Q2 2015.
  • 198 funds tracked by Wall St. Rank held Axon Enterprise as of Q3 2015.

Based on Integral Derivatives's 13F filing for Q3 2015, filed 15 Oct 2015.